Sylvester Comprehensive Cancer Center/ University of Miami — Miami, Florida

Sylvester Comprehensive Cancer Center/ University of Miami is a clinical research site located in Miami, Florida, United States 33136.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Sylvester Comprehensive Cancer Center/ University of Miami has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD).

Sponsors: Pierre Fabre Medicament.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sylvester Comprehensive Cancer Center/ University of Miami?

Sylvester Comprehensive Cancer Center/ University of Miami has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sylvester Comprehensive Cancer Center/ University of Miami conducted?

Sylvester Comprehensive Cancer Center/ University of Miami has 1 clinical trials on record, with 1 currently active. Their work covers Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD).

Is Sylvester Comprehensive Cancer Center/ University of Miami accredited by Crixeo Health?

Sylvester Comprehensive Cancer Center/ University of Miami has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sylvester Comprehensive Cancer Center/ University of Miami?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.